logo

For the Inventor, By the Inventor

Ghent, Belgium

Pierre Jean De Clercq

This inventor holds 8 USPTO granted patents and 2 EPO patents. Top assignees: K.u. Leuven Research & Development, University of Ghent, Agfa Gevaert Nv. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Jean De Clercq. Retrieved from https://idiyas.com/inventor/pierre-jean-de-clercq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 62.5


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Gent, BE (1997 - 2011)
  • Ghent, BE (2000 - 2012)

Company Filing History:

goldMedal3 out of 84 
 
K.u. Leuven Research & Development
 patents
silverMedal3 out of 505 
 
University of Ghent
 patents
bronzeMedal2 out of 1,313 
 
Agfa Gevaert Nv
 patents
4. 2 out of 7 
 
Laboratoire Theramex S.a.
 patents
5. 1 out of 16 
 
Laboratoire Theramex
 patents
where one patent can have more than one assignee

Years Active: 1997-2012

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 8258126 - [object Object] (2012-09-04),
2. 7888338 - 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes (2011-02-15),
3. 7704986 - [object Object] (2010-04-27),
4. 6548715 - Structural analogues of vitamin D (2003-04-15),
5. 6191292 - Precursors of the A-ring of vitamin D and method and intermediates for the preparation thereof (2001-02-20),
6. 6017907 - Structural analogues of vitamin D (2000-01-25),
7. 5998087 - Photographic material containing a new hydrazide type (1999-12-07),
8. 5631125 - Photographic useful group releasing system (1997-05-20),

Title: The Innovations of Pierre Jean De Clercq

Introduction

Pierre Jean De Clercq is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of vitamin D analogues and other innovative compounds. With a total of eight patents to his name, De Clercq's work has had a substantial impact on the prevention and treatment of bone disorders.

Latest Patents

One of his latest patents focuses on novel vitamin D analogues that are useful for making pharmaceutical compositions aimed at preventing or treating bone disorders such as osteoporosis. Another significant invention is related to 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes, which includes compositions that comprise these compounds and methods for treating various diseases and illnesses.

Career Highlights

Throughout his career, De Clercq has worked with esteemed institutions such as K.U. Leuven Research & Development and Universiteit Gent. His research has contributed to advancements in pharmaceutical sciences, particularly in the area of bone health.

Collaborations

De Clercq has collaborated with notable colleagues, including Maurits E Vandewalle and Roger Bouillon, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

Pierre Jean De Clercq's innovative work in pharmaceuticals, particularly in the development of vitamin D analogues and spiro compounds, showcases his dedication to improving health outcomes. His contributions continue to influence the field and inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…